New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
VectivBio Holding AG
VECT
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

1B

Biotechnology

16.87USD
Shape0.02 ( 0.12%)
Market Open
favorite-chart

Relative Strenght

98
favorite-chart

Volume Buzz

-88%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

1%

Quote Panel

Shape
Updated October 22, 2024
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap

    1.06B


  • Shares Outstanding

    62.81M


  • Share in Float


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    16.87


  • Average Volume

    1.10M


  • Beta

    0.101083


  • Range

    4.25-16.98


  • Industry

    Biotechnology


  • Website

    https://vectivbio.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

38.75x

P/S Ratio

3.49x

P/B Ratio

0.0

Debt/Equity

-342.8%

Net Margin

$-2.1

EPS

How VECT compares to sector?

P/E Ratio

Relative Strength

Shape

VECT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Jefferies

initialise

Previous: Not converted

2022-12-13

Now: Buy

Piper Sandler

initialise

Previous: Not converted

2022-07-01

Now: Overweight

Zacks Investment Research

upgrade

Previous: Not converted

2022-04-26

Now: Hold

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.20

arrow
arrow

N/A

-0.65
vs -0.25

Q2.20

arrow
arrow

N/A

-0.65
vs -0.25

Q3.20

arrow
arrow

N/A

-0.65
vs -0.25

Q4.20

arrow
arrow

N/A

-0.65
vs -0.25

Q1.21

arrow
arrow

N/A

-0.81
vs -0.65

Q2.21

arrow
arrow

N/A

-0.81
vs -0.65

Q3.21

arrow
arrow

N/A

-0.81
vs -0.65

Q4.21

arrow
arrow

N/A

-0.81
vs -0.65

Q4.22

arrow
arrow

N/A

-0.65
vs -0.81

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.20

arrow
arrow

NA

NA  vs NA

Q2.20

arrow
arrow

NA

NA  vs NA

Q3.20

arrow
arrow

NA

NA  vs NA

Q4.20

arrow
arrow

NA

NA  vs NA

Q1.21

arrow
arrow

NA

NA  vs NA

Q2.21

arrow
arrow

NA

NA  vs NA

Q3.21

arrow
arrow

NA

NA  vs NA

Q4.21

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

676K  vs NA

Return on EquityShape

status-upQoQ

Q4.20

arrow
arrow

-47%

-0.47
vs -1.88

Q1.21

arrow
arrow

-75%

-0.75
vs -0.47

Q2.21

arrow
arrow

-15%

-0.15
vs -0.75

Q3.21

arrow
arrow

-75%

-0.75
vs -0.15

Q4.21

arrow
arrow

-19%

-0.19
vs -0.75

Q2.22

arrow
arrow

NA

NA
vs -0.19

Q4.22

arrow
arrow

-13%

-0.13
vs NA

Q2.23

arrow
arrow

NA

NA
vs -0.13

Institutionnal OwnershipShape

status-upQoQ

Q2.22

arrow
arrow

20

20
vs 16

25%

Q3.22

arrow
arrow

21

21
vs 20

5%

Q4.22

arrow
arrow

28

28
vs 21

33%

Q1.23

arrow
arrow

35

35
vs 28

25%

Q2.23

arrow
arrow

53

53
vs 35

51%

Q3.23

arrow
arrow

2

2
vs 53

-96%

Q4.23

arrow
arrow

1

1
vs 2

-50%

Q1.24

arrow
arrow

1

1
vs 1

NA

Earnings Growth

Latest News